{"id":809362,"date":"2025-02-05T16:12:48","date_gmt":"2025-02-05T21:12:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/"},"modified":"2025-02-05T16:12:48","modified_gmt":"2025-02-05T21:12:48","slug":"mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/","title":{"rendered":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">RADNOR, Pa., Feb.  05, 2025  (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2024, before the financial markets open on Wednesday, February 12, 2025.<\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td>\n            <strong><br \/>\n              <em><br \/>\n                <u>Wednesday, February 12<\/u><br \/>\n              <\/em><br \/>\n            <\/strong><br \/>\n            <sup><br \/>\n              <strong><br \/>\n                <em><br \/>\n                  <u>th<\/u><br \/>\n                <\/em><br \/>\n              <\/strong><br \/>\n            <\/sup><br \/>\n            <strong><br \/>\n              <em><br \/>\n                <u> @ 8:30 a.m. ET<\/u><br \/>\n              <\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Domestic:<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle\">1-800-717-1738<\/td>\n<\/tr>\n<tr>\n<td>International:<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle\">1-646-307-1865<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: middle\">\n            <a href=\"https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1702883&amp;tp_key=d0a66243a8\" rel=\"nofollow\" target=\"_blank\">Link<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>A live webcast of the conference call may also be found on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Rkc30iDAacbDwOWnk1OWhe8KFpmSXaD_mFPsNrCWWp68RdSbv6qyznypdusN60ONArZ2-zrgpe8Vrg3j5kW8w-2Ad3TCAk6dMu6qm9Co_4Y=\" rel=\"nofollow\" target=\"_blank\">News &amp; Events<\/a>\u201d page in the Investor Relations section of the Mineralys Therapeutics website.<\/p>\n<p>\n        <strong>About\u00a0Mineralys Therapeutics<\/strong><br \/>\n        <br \/>Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that Mineralys Therapeutics is developing for cardiorenal conditions affected by dysregulated aldosterone, including hypertension, CKD and OSA. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lo1_9u8PbuP8SGOGzDNP54zmlteZ_6iCw4lEpQ37R1AzdOGA828jNhYp93cGVHGDwlT9PG9I8mJAkB-gzcNVYkd_ZlvgF95X8eO2-FZqtLE=\" rel=\"nofollow\" target=\"_blank\">https:\/\/mineralystx.com<\/a>. Follow Mineralys on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2wPRcksRzPrOW3ImVQ2eB_KlO1wkZ79OfPGPQaV3uWlnBDsG2FYN18VrDDS34Z4yeOKIvhSzeJb7d_AiEWH41jFjXjPK6DHWlRXBP8vjqqnl7XriqgPFK5AcvrENODJW7eo9hScidgsDTLVST9Pz9A==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=waZ7c9cEJzgvSh7ILxsanunIXQ1zRFbldj3C8B6rV4Tu5VH-LWuH0wd_FLAsWcFbYW3LbdEYEZi-kO0wUPxouQ-qp3bgHPdO_vGvJqonZQ90RoH1gTZH8oxYvSV9RQdR_aBqxwggVs-nw_fH-r5cxw==\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations<br \/><\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ekWy5_RCiDh4udN4h4wHJD3A6IlBb1VZhMxfT54-SqtQbk02mSyO1s8KW6jALpM60akKFkCyrDLWg2nABQNgfBfgcQv6FBiSK7VUtitEGWvAqt5f9TcfYiKmME5eD4NcxTqoh09eEuggBnKnwDdn_Q==\" rel=\"nofollow\" target=\"_blank\">investorrelations@mineralystx.com<\/a>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media Relations<br \/><\/strong>Tom Weible<br \/>Elixir Health Public Relations<br \/>Phone: (1) 515-707-9678<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h6nUlXe3URnDaTQ54PXhd7RuCOGDEJy4xzvelGwLhM3j4Q74adw6b4Z6TnOu6nHyna9yL9P-N15lvi1JbBhaoi4nX_aI6M-ne_ApwAihu-db2fwbgvvAZr4tcerVD4E3\" rel=\"nofollow\" target=\"_blank\">tweible@elixirhealthpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTZjZmVhY2MtYzRjYS00NTI4LTk2NTQtYTZiNzQ2MGMyYjdiLTUwMDExMzcwMQ==\/tiny\/Mineralys-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2024, before the financial markets open on Wednesday, February 12, 2025. Wednesday, February 12 th @ 8:30 a.m. ET \u00a0 Domestic: 1-800-717-1738 International: 1-646-307-1865 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809362","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2024, before the financial markets open on Wednesday, February 12, 2025. Wednesday, February 12 th @ 8:30 a.m. ET \u00a0 Domestic: 1-800-717-1738 International: 1-646-307-1865 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused &hellip; Continue reading &quot;Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T21:12:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025\",\"datePublished\":\"2025-02-05T21:12:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/\"},\"wordCount\":226,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/\",\"name\":\"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\",\"datePublished\":\"2025-02-05T21:12:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/","og_locale":"en_US","og_type":"article","og_title":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk","og_description":"RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2024, before the financial markets open on Wednesday, February 12, 2025. Wednesday, February 12 th @ 8:30 a.m. ET \u00a0 Domestic: 1-800-717-1738 International: 1-646-307-1865 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused &hellip; Continue reading \"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T21:12:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025","datePublished":"2025-02-05T21:12:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/"},"wordCount":226,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/","name":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==","datePublished":"2025-02-05T21:12:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1Mjg2MCM2NzM1MzAyIzUwMDExMzcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-wednesday-february-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809362"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809362\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}